Nuvectis Pharma Inc

Market Cap

$255M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$9.54+$1.03 (+12.10%)

Jun 5, 2026

52W High $12.4552W Low $5.65

Company Details

Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. The company is developing NXP900, a small molecu...

CEO

—

IPO Date

Feb 4, 2022

Website

www.nuvectis.com

Key Metrics TTM

Revenue

-100.0% YoY

Net Income

-$27M

EPS (Diluted)

Free Cash Flow

-$18M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q2 2026

Aug 4, 2026

PENDING

Q1 2026

May 5, 2026

FY 2025

Feb 11, 2026

Q4 2025

Feb 11, 2026

$0-100.0%

Q3 2025

Nov 4, 2025

Revenue & Profitability

Valuation

Operating Cash Flow

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee